Burcu Kilic

Burcu Kilic

Auto-generated profile, based on publicly available information

Burcu Kilic

Gazi Üniversitesi

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MEMerve Erdogan
Merve Erdogan
BKBurcu Kilic
Burcu Kilic
RSRahsan Ilıkcı Sagkan
Rahsan Ilıkcı Sagkan
FAFatma Aksakal
Fatma Aksakal
TETugba Ercetin
Tugba Ercetin
DDDeniz S. Dogruer
Deniz S. Dogruer

1 September 2018 in Bioorganic Chemistry
Verified
Journal Article
Closed access
BKBurcu Kilic
Burcu Kilic
HGHayrettin Gulcan
Hayrettin Gulcan
FAFatma Aksakal
Fatma Aksakal
TETugba Ercetin
Tugba Ercetin
NONihan Oruklu
Nihan Oruklu
DDDeniz S. Dogruer
Deniz S. Dogruer

5 June 2023 in Archiv der Pharmazie
Verified
Journal Article
Open access
MBMerve Bardakkaya
Merve Bardakkaya
BKBurcu Kilic
Burcu Kilic
RSRahsan Ilıkcı Sagkan
Rahsan Ilıkcı Sagkan
FAFatma Aksakal
Fatma Aksakal
SSShakila Shakila
Shakila Shakila
DDDeniz S. Dogruer
Deniz S. Dogruer
In this study, two diverse series of 2‐aminothiazole‐based multitarget compounds, one propenamide and the other propanamide derivatives, were designed and synthesized. Subsequently, their anticholinesterease and antioxidant (ORAC) activities were tested. Among them, compound 3e was the most potent acetylcholinesterase (AChE) inhibitor (AChE IC50 = 0.5 μM, butyrylcholinesterase [BChE] IC50 = 14.7 μM) and compound 9e was the most potent BChE inhibitor (AChE IC50 = 3.13 μM, BChE IC50 = 0.9 μM). Kinetic experiments showed that both compounds were mixed‐type inhibitors. According to the anticholinesterease activity results, five compounds (3e, 4e, 5e, 9d, and 9e) were selected for further activity studies, all of which are dual cholinesterase inhibitors. Then, selected compounds were investigated in terms of their metal chelation activity. Moreover, their neuroprotective effects against H2O2‐induced damage in the PC12 cell line were evaluated at 10 μM and the results showed that the neuroprotective effect of 3e was 53% compared with the reference ferulic acid (77%). 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) results of selected compounds revealed that the compounds were noncytotoxic. Additionally, 3e was more effective in reducing lipopolysaccharides‐induced interleukin‐1β (IL‐1β), IL‐6, tumor necrosis factor‐α (TNF‐α), and nitric oxide (NO) production in the human monocyte derived from patient with acute monocytic leukemia cell line compared with other selected compounds. Finally, a molecular docking study was also performed.

7 January 2019 in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
BKBurcu Kilic
Burcu Kilic
MEMerve Erdogan
Merve Erdogan
HGHayrettin O. Gulcan
Hayrettin O. Gulcan
FAFatma Aksakal
Fatma Aksakal
NONihan Oruklu
Nihan Oruklu
DDDeniz S. Dogruer
Deniz S. Dogruer
Background: With respect to the increase in the average life expectancy, Alzheimer Disease (AD), the most common form of age-related dementia, has become a major threat to the population over the age of 65 during the past several decades. The majority of AD treatments are focused on cholinergic and amyloid hypotheses.Objective: In this study, three series of diphenyl-2-(2-(4-substitutedpiperazin-1-yl)ethyl)pyridazin- 3(2H)-one derivatives were designed, synthesized and investigated for their ability to inhibit both cholinesterase enzymes and amyloid-β aggregation.Method: The inhibitory activities of the synthesized compounds on AChE (from electric eel) and BChE (from equine serum) were determined by the modified Ellman’s method. The reported thioflavin T-based fluorometric assay was performed to investigate the effect of the selected compounds on the aggregation of Aβ1-42. The cytotoxic effect of the compounds (4g, 11g and 18g) was monitored in 3T3 cell lines to gain insight into therapeutic potential of the compounds by using MTT assay. The crystal structures of the AChE (1EVE) and BChE (1P0I) enzymes were retrieved from the RCSB Protein Data Bank and Molecular Operating Environment (MOE) software was used for molecular docking of the ligands.Results: Among the tested compounds, 5,6-diphenyl derivative 18g was identified as the most potent and selective AChE inhibitor (IC50 = 1.75 µM, Selectivity Index for AChE > 22.857). 4,6- Diphenyl derivative 11g showed the highest and the most selectivity for BChE (IC50= 4.97 µM, SI for AChE < 0.124). Interestingly, 4,5-diphenyl derivative 4g presented dual cholinesterase inhibition (AChE IC50= 5.11 µM; BChE IC50= 14.16 µM, SI for AChE = 2.771).Conclusion: Based on biological activity results and low toxicity of the compounds, it can be said that diphenyl substituted pyridazinone core is a valuable scaffold. Especially, dual inhibitory potencies of 4,5-diphenylpyridazin-3(2H)-one core for the cholinesterase enzymes and Aβ- aggregation makes this core a promising disease-modifying agent.

16 April 2024 in Drug Development Research
Verified
Journal Article
Open access
BKBurcu Kilic
Burcu Kilic
DDDeniz S. Dogruer
Deniz S. Dogruer
One of the worst long‐term health issues of the past few decades is Alzheimer's disease (AD). Unfortunately, there are currently insufficient choices for treating and caring for AD, which makes it a popular subject for drug development research. Studies on the development of drugs for AD have primarily concentrated on the use of multitarget directed ligands. Following this strategy, we designed new ChE inhibitors with additional antioxidant and metal chelator effects. In this research, eight novel N’‐(quinolin‐4‐ylmethylene)propanehydrazide derivatives were synthesized and characterized. We then evaluated the inhibition potency of all the final compounds for cholinesterase enzymes. Among them, 4e (IC50 acetylcholinesterase [AChE] = 0.69 µM and butyrylcholinesterase [BChE]= 26.00 µM) and 4h (IC50's AChE= 7.04 µM and BChE= 16.06 µM) were found to be the most potent AChE and BChE inhibitors, respectively.